A. Lally
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
A. Lally has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
F. Wojnarowska
Department of Dermatology, Oxford Radcliffe Hospitals, Oxford, UK
2 shared publicationsR. Turner
Departments of Dermatology
2 shared publicationsA. Chamberlain
Departments of Dermatology, Oxford Radcliffe Hospitals, Oxford, UK, and Alfred Hospital, Prahran, Victoria, Australia
1 shared publicationC Clelland
Department of Histopathology, Oxford Radcliffe Hospitals, Oxford, UK
1 shared publicationD. Dean
Departments of Dermatology, Oxford Radcliffe Hospitals, Oxford, UK, and Alfred Hospital, Prahran, Victoria, Australia
1 shared publicationF Charnock
1 shared publication
Latest Publications
- 1 October 2007
- Published by Wiley in British Journal of Dermatology
- Vol. 157 (4) , 815-816
Central nervous system involvement in stage 1b mycosis fungoides
- 1 October 2007
- Published by Wiley in British Journal of Dermatology
- Vol. 157 (4) , 815-816
Central nervous system involvement in stage 1b mycosis fungoides
- 1 May 2007
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 32 (3) , 268-271
Hypertrophic pseudofolliculitis in white renal transplant recipients
Renal transplant recipients (RTRs) are susceptible to many cutaneous disorders, including drug-induced skin changes. Hypertrichosis, sebaceous hyperplasia and gingival hyperplasia are well-recognized effects of ciclosporin, one of the immunosuppressants commonly used in RTRs. Pseudofolliculitis barbae usually affects hair-bearing areas of skin in men with darkly pigmented skin who shave on a regular basis. We describe five cases of hyperplastic pseudofolliculitis occurring in white RTRs taking ciclosporin as part of their immunosuppressive regimen. All five had involvement of the chin, the classic site of pseudofolliculitis barbae, and two had additional psuedofolliculitis of the nose or occiput.
- 1 May 2007
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 32 (3) , 268-271
Hypertrophic pseudofolliculitis in white renal transplant recipients
Renal transplant recipients (RTRs) are susceptible to many cutaneous disorders, including drug-induced skin changes. Hypertrichosis, sebaceous hyperplasia and gingival hyperplasia are well-recognized effects of ciclosporin, one of the immunosuppressants commonly used in RTRs. Pseudofolliculitis barbae usually affects hair-bearing areas of skin in men with darkly pigmented skin who shave on a regular basis. We describe five cases of hyperplastic pseudofolliculitis occurring in white RTRs taking ciclosporin as part of their immunosuppressive regimen. All five had involvement of the chin, the classic site of pseudofolliculitis barbae, and two had additional psuedofolliculitis of the nose or occiput.
- 24 April 2007
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 32 (5) , 493-498
Dermal-binding linear IgA disease: an uncommon subset of a rare immunobullous disease
Background. Linear IgA disease (LAD) is an acquired subepidermal blistering disorder, characterized clinically by urticated plaques, papules, vesicles and bullae. Scarring is not usually observed. Direct immunofluorescence on clinically uninvolved skin shows linear deposition of IgA at the basement membrane zone (BMZ). Indirect immunofluorescence on salt‐split skin shows dermal binding in a minority of cases. Aim. To identify and characterize patients with LAD who have IgA anti‐BMZ autoantibodies directed against the dermal side of salt‐split human skin (dermal‐binding autoantibodies). Methods. This was a retrospective study of patients with a diagnosis of LAD referred to the dermatology department in Oxford between 1986 and 2004, who demonstrated dermal‐binding circulating IgA autoantibodies on indirect immunofluorescence. Clinical features were reviewed and target antigens identified by immunoblotting. Results. In total, 17 of 101 patients with LAD were found to have dermal‐binding autoantibodies. This subset of LAD was relatively more common in adults than in children. There were no other clinical features that distinguished these patients from others with LAD. Collagen VII, the target antigen in epidermolysis bullosa acquisita (EBA), was identified in two of our cohort, but none of the classic clinical features of mechanobullous EBA was observed. Conclusion. This is the largest cohort of patients with dermal‐binding LAD to date. Our patients were clinically indistinguishable from those with non dermal‐binding LAD, and showed no evidence of the classic mechanobullous EBA phenotype.
- 24 April 2007
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 32 (5) , 493-498
Dermal-binding linear IgA disease: an uncommon subset of a rare immunobullous disease
Background. Linear IgA disease (LAD) is an acquired subepidermal blistering disorder, characterized clinically by urticated plaques, papules, vesicles and bullae. Scarring is not usually observed. Direct immunofluorescence on clinically uninvolved skin shows linear deposition of IgA at the basement membrane zone (BMZ). Indirect immunofluorescence on salt‐split skin shows dermal binding in a minority of cases. Aim. To identify and characterize patients with LAD who have IgA anti‐BMZ autoantibodies directed against the dermal side of salt‐split human skin (dermal‐binding autoantibodies). Methods. This was a retrospective study of patients with a diagnosis of LAD referred to the dermatology department in Oxford between 1986 and 2004, who demonstrated dermal‐binding circulating IgA autoantibodies on indirect immunofluorescence. Clinical features were reviewed and target antigens identified by immunoblotting. Results. In total, 17 of 101 patients with LAD were found to have dermal‐binding autoantibodies. This subset of LAD was relatively more common in adults than in children. There were no other clinical features that distinguished these patients from others with LAD. Collagen VII, the target antigen in epidermolysis bullosa acquisita (EBA), was identified in two of our cohort, but none of the classic clinical features of mechanobullous EBA was observed. Conclusion. This is the largest cohort of patients with dermal‐binding LAD to date. Our patients were clinically indistinguishable from those with non dermal‐binding LAD, and showed no evidence of the classic mechanobullous EBA phenotype.
- 1 March 2007
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 156 (3) , 575-576
A survey of approach to wound healing by secondary intention among British Society for Dermatological Surgery members
- 1 March 2007
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 156 (3) , 575-576
A survey of approach to wound healing by secondary intention among British Society for Dermatological Surgery members
- 12 December 2006
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 21 (3) , 434-435
A unique paraneoplastic syndrome presenting in a patient with unresectable thymoma
- 12 December 2006
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 21 (3) , 434-435
A unique paraneoplastic syndrome presenting in a patient with unresectable thymoma
- 27 November 2006
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 21 (3) , 407-408
Multiple vulval basal cell carcinomas
- 27 November 2006
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 21 (3) , 407-408
Multiple vulval basal cell carcinomas